• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

The Lancet. Genesis of avian-origin H7N9 influenza A viruses

Giuseppe

Emeritus
[Source: The Lancet, full text: (LINK). Extract.]
The Lancet, Early Online Publication, 2 May 2013

doi:10.1016/S0140-6736(13)60959-9

Genesis of avian-origin H7N9 influenza A viruses

Original Text

Marc Van Ranst, Philippe Lemey


Since March, 2013, 126 laboratory-confirmed cases of avian influenza A H7N9 have been detected in ten provinces or municipalities in east and southeast China (as of April 30, 2013). Most H7N9-infected patients are older (approximate median age 62 years) urban men who reported exposure to chickens or captive-bred pigeons either professionally or through visits to live poultry markets. Patients rapidly develop progressive pneumonia leading to acute respiratory distress syndrome and multiorgan failure. The case fatality rate seems to be roughly 20%,5 although this early estimated rate will probably prove to be inflated when the denominator increases upon detection of more moderate, mild, or asymptomatic infections through seroepidemiological studies.

(?)
-
------
 

Attachments

Back
Top